Search
SHAREHOLDER ACTION: Dalton Gooding and William Dolphin are the two casualties from Avita Medical's AGM. Photo: Attila Csaszar

Dolphin steps down as Avita CEO

William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
218thHotCopper Holdings50%0%
302ndGoldfields Money27%5%
496thWestStar Industrial-4%-54%
541stAvita Medical-10%-10%
799thSprintex-68%-33%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

90th↑Avita Medical$8.0m
100th↑WestStar Industrial$4.6m
101st↓Goldfields Money$4.2m
103rd↓Sprintex$4.1m
105th↑HotCopper Holdings$4.0m
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

213thTim Rooney$506k
315thAndrew Quick$366k
575thLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer